Thomas A. Vecchiolla
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Thomas A. Vecchiolla
Thomas A. Vecchiolla is recorded as CEO and Chairman at Calidi Biotherapeutics, Inc. (CLDI). Calidi Biotherapeutics, Inc. reported in an 8-K filed December 27, 2022 that Thomas A. Vecchiolla was appointed Chairman of the Board, effective December 22, 2022. Calidi Biotherapeutics, Inc. reported in an 8-K filed December 27, 2022 that Thomas A. Vecchiolla was appointed sole Chief Executive Officer, effective December 22, 2022. Calidi Biotherapeutics, Inc. reported in an 8-K filed September 16, 2022 that Thomas A. Vecchiolla was appointed co-Chief Executive Officer, effective September 15, 2022.
“Effective as of December 22, 2022, Thomas A. Vecchiolla will serve as sole Chief Executive Officer and Chairman of the Board.”
“Effective as of December 22, 2022, Thomas A. Vecchiolla will serve as sole Chief Executive Officer and Chairman of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-12-22–present
-
Current
2022-12-22–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Calidi Biotherapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Eric Poma, Ph.D. CEO, Board Member
- James Schoeneck Chairman, Board Member
- Andrew Jackson CFO
- George Ng COO, Board Member
- Alfonso Zulueta Board Member
- Allan Camaisa Board Member
- David LaPre Board Member
- Dr. Corazon (Corsee) Sanders Board Member
- Dr. George Peoples Board Member
- Eric Poma Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.